RecruitingNot applicableNCT03047369
The Myelin Disorders Biorepository Project
Studying Leukodystrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Children's Hospital of Philadelphia
- Principal Investigator
- Adeline Vanderver, MDChildren's Hospital of Philadelphia
- Enrollment
- 12000 enrolled
- Eligibility
- All sexes
- Timeline
- 2016 – 2030
Study locations (20)
- Children's Hospital of Los Angeles, Los Angeles, California, United States
- Children's Hospital of Orange County, Orange, California, United States
- Stanford University (Lucile Packard Children's Hospital), Palo Alto, California, United States
- University of California, Davis (UC Davis Health), Sacramento, California, United States
- University of California, San Diego (Rady Children's Hospital), San Diego, California, United States
- UCSF Benioff Children's Hospital, San Francisco, California, United States
- Children's National Medical Center, Washington D.C., District of Columbia, United States
- Emory University (Children's Healthcare of Atlanta), Atlanta, Georgia, United States
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
- Kennedy Krieger Institute, Baltimore, Maryland, United States
- Massachusetts General Hospital (MGH), Boston, Massachusetts, United States
- University of Minnesota, Minneapolis, Minnesota, United States
- Mayo Clinic, Rochester, Minnesota, United States
- Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina, United States
- Akron Children's Hospital, Akron, Ohio, United States
- +5 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03047369 on ClinicalTrials.govOther trials for Leukodystrophy
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT07222371An Open-label, Single Center, Single Participant Study of an Experimental Antisense Oligonucleotide Treatment for TUBB4A-related LeukodystrophyUniversity of California, San Diego
- ENROLLING BY INVITATIONPHASE1, PHASE2NCT06369974Single Participant Study of an Experimental ASO Treatment for TUBB4A-related LeukodystrophyMassachusetts General Hospital
- RECRUITINGNANCT06224413A Study of Participants With Cerebral Adrenoleukodystrophy (CALD) Treated With Elivaldogene AutotemcelGenetix Biotherapeutics Inc.
- RECRUITINGPHASE3NCT05819866A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral AdrenoleukodystrophyMinoryx Therapeutics, S.L.
- RECRUITINGPHASE1, PHASE2NCT05757141An Open-Label Exploratory Study of Fosigotifator in Participants With Vanishing White Matter DiseaseCalico Life Sciences LLC
- RECRUITINGPHASE1NCT02254863UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like CellsJoanne Kurtzberg, MD
- RECRUITINGNCT03639285Natural History, Diagnosis, and Outcomes for LeukodystrophiesUniversity of Utah